XDemics is a biotechnology company pioneering next-generation cell culture and bioproduction technologies that dramatically improve the efficiency and scalability of life science workflows. We address one of the most critical bottlenecks in biomedical research and manufacturing: the ability to reliably grow high-quality mammalian cells at scale, including CAR-T, MSCs, stem cells, and so much more! At the core of XDemics’ platform is our patented High Density Cell Respiration™ technology, which enables cells to grow at 10–100× higher densities beyond conventional methods by optimizing oxygen delivery and cellular microenvironments. This breakthrough drives significant gains in productivity, reproducibility, and cost efficiency, accelerating timelines from discovery to commercialization. XDemics’ solutions span from advanced cultureware to scalable bioreactor systems, supporting applications across cell and gene therapies, monoclonal antibody (mAb) production, and oncolytic virus manufacturing. By enabling seamless scale-up from benchtop research to industrial production, we empower scientists and biopharma organizations to bring innovative therapies to market faster and more affordably. Through our platform, XDemics is redefining bioproduction, unlocking higher yields, lower costs, and broader access to next-generation medicines.
VivoTex LLC
VivoTex offers 3D printed microfiber scaffolds that are engineered to help researchers replicate tissue models more effectively than other currently available 3D scaffolds, matrices, or bioinks. Our founders co-invented a technology called melt electrowriting (MEW) that allows for more precise control over the cell micro-environment, accelerating cell growth, enhancing cell-to-cell communication, and boosting cell viability to improve outcomes, speed, and reproducibility.
TETHIS SPA
Tethis S.p.A., an Italian diagnostic firm, has pioneered titanium dioxide–nanocoated SmartBioSurface® slides that enable in‑situ analysis of typically non‑adherent cells – including primary cells, stem cells, and PBMCs. These slides are ideally suited for multiplex and multiomic assays, advanced spatial biology techniques, and precise single‑cell laser‑capture microdissection. In addition, Tethis has developed See.d®, an automated instrument for pre‑analytical sample preparation in liquid biopsy. See.d® introduces a new level of standardization and reliability by fully automating plasma and cytology sample processing – addressing two major unmet needs in liquid biopsy workflows: the lack of reproducible, standardized pre‑analytical protocols and the difficulty of visualizing and analysing rare tumor and immune cells on microscopy slides.
SARSTEDT
As a globally operating family-owned company, we have been a leading partner in medicine and science for over six decades. With more than 3,000 employees, we develop solutions that drive progress in pre-analytics and life science, enhancing patient care and setting new standards in scientific research. Our solutions span sample collection, liquid handling, cell culture, molecular biology, and laboratory automation. With a clear focus on safety, precision, and efficiency, we ensure that healthcare professionals and researchers can trust our products to deliver high-quality, reproducible results. For those working in molecular diagnostics, personalized medicine, or laboratory automation, SARSTEDT offers leading expertise and products that meet the highest quality and performance standards. Let’s advance healthcare and medical research together with the innovative and sustainable solutions you need.
Resonant Clinical Solutions
Resonant Clinical Solutions delivers end-to-end clinical trial and diagnostic services designed to accelerate science. Building on a strong legacy in life sciences logistics, we provide comprehensive solutions that go beyond supply fulfillment—offering agile collaboration and personalized support as an extension of your team. Our expertise spans biorepository management, custom kitting and global logistics, and equipment & ancillary services, ensuring every detail of your research workflow is handled with precision. From procurement and delivery to calibration and recovery, we simplify complex processes while maintaining strict compliance with international standards. With strategically located service centers and a global partner network, we combine technical and regulatory insight with proven experience to serve customers worldwide. At Resonant Clinical Solutions, we’re committed to problem-solving, innovation, and helping research and clinical teams move science forward.
REPROCELL/BioServe
REPROCELL is a global leader providing researchers with integrated tools for translational research including biospecimens, molecular biology services, iPSC, CRISPR, human fresh tissue assays and 3D cell culture. For oncology researchers we have a large inventory of cancer tissues and biofluids, DNA/RNA, matched sample sets, samples with mutation information and can perform drug toxicity (IC50) analysis for compounds of interest using normal and cancer cell lines.
Precision Biosystems
Precision Biosystems is Massachusetts based company that provides instrumental solution to the difficult problems of laboratory automation. Precision Biosystems is a developer and manufacturer of a BlotCycler, an automated western blot processor, based on patented fluid distribution technology. All steps after protein transfer to a membrane are fully automated: shaking, blocking, hybridization, washing, and recycling of primary antibody. BlotCycler offers unique advantages over existing technologies in using immunoblotting for research and clinical work. Unique fluidic-based washing technology allows significant increase in sensitivity and requires less antibodies. The introduction of BlotCycler made consistent, reproducible, and high quality western blot a reality. Check our website: http://precisionbiosystems.com/freetrial/
OZ BIOSCIENCES
OZ Biosciences creates, develops and produces innovative molecular delivery systems specialized in transfection reagents (Magnetofection, Lipofection, Polyfection) and transduction tools (viral enhancers), mRNA (catalog and custom service), LNP: Lipid nanoparticles formulation (catalog and custom service), PNPs, adjuvants, bioproduction reagents (virus and protein production) and assay kits, for the worldwide scientific community and pharmaceutical industry. OZ Biosciences is focused on delivery technologies of biomolecules such as DNA, RNA and proteins for in vitro and in vivo applications.
MP Biomedicals
MP Biomedicals is a global leader in life sciences and diagnostics, providing high-quality research tools and reagents to support cancer research, drug discovery, and molecular biology applications. With a comprehensive portfolio spanning nucleic acid extraction, cell culture, immunoassays, and protein analysis, we empower scientists with reliable solutions for advancing biomedical breakthroughs. Our commitment to innovation and quality ensures researchers have the resources they need to drive discoveries from bench to bedside.
MilliporeSigma
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is committed to advancing cancer research. Our extensive portfolio of over 300,000 products supports the development of novel therapies, diagnostics, and prevention strategies. We offer solutions across key areas, including molecular tools, sample preparation, antibodies, cell culture, live cell analysis, biochemicals, and biomarker immunoassays. Cancer research is a multidisciplinary effort, and we provide integrated tools that accelerate progress at every stage—from basic to clinical research. Our molecular tools allow researchers to study cancer’s genetic and molecular foundations, while our high-quality antibodies enable the detection of proteins involved in cancer progression. MilliporeSigma also offers advanced sample preparation technologies for analyzing DNA, RNA, and proteins from tumor samples, and live cell analysis platforms for real-time insights into cellular behaviors and drug responses. Our biomarker immunoassays help identify cancer biomarkers and monitor treatment efficacy, supporting the development of early detection tests and personalized medicine. We are dedicated to empowering researchers with innovative solutions that help advance cancer prevention, detection, and treatment. MilliporeSigma is your trusted partner in tackling cancer biology complexities, accelerating breakthroughs, and realizing a future where cancer is more treatable and preventable. | As a leading science and technology company, we uniquely combine three specialized, innovation-driven businesses: Life Science, Healthcare, and Electronics. We utilize our multi-industry expertise to address a wide spectrum of global challenges. By supplying advanced scientific research and biotechnological manufacturing products, developing therapies for serious diseases, and providing high-performance materials for semiconductors and displays, we contribute to improving health, scientific progress, and technology for people around the world. | MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. We are built to serve you in your drug development journey – as one trusted partner. Whether you need Millipore® CTDMO services, with decades of development, manufacturing, and testing expertise, to deliver a streamlined experience, or standalone industry-leading BioReliance® contract testing services and analytical development, we are built to serve you – to accelerate your milestones and breakthroughs. | MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, leverages over 35 years of CDMO experience and 75 years of contract testing services to redefine the industry CDMO model for today’s dynamic market needs. Our integrated Millipore® CTDMO Services offer expertise in development, manufacturing, contract testing, and technologies from pre-clinical to commercial stages, serving as a single experienced partner to accelerate your milestones and breakthroughs. With extensive experience in mRNA & LNP Formulation, ADC, Small Molecule, Biologics, and Viral Vector, we are dedicated to supporting your drug development journey as a trusted partner. Whether you seek a streamlined experience with a single partner or standalone industry-leading BioReliance® contract testing services and analytical development, we are committed to accelerating your milestones and breakthroughs while forging partnerships aimed at bringing breakthroughs to life to ultimately help patients. 2025 North America Advance Biotech Grant Award Ceremony Join us in the Start-up Stadium at 1:30pm, June 17th, to hear from our finalists and discover who will receive $258,000 in bioprocessing technologies, bioprocessing consulting services, contract testing services, and a full subscription to Emprove® Premium. The next round of applications will open in early 2026. | From the first spark of discovery to full-scale manufacturing, we stand beside you with the products, services, and expertise to help you move with speed and confidence. As a global leader in life science, MilliporeSigma supports innovators across biotech and pharma with 300,000+ products and comprehensive solutions all designed to help you progress from early research through process development, scale-up, and manufacturing. What you can explore with us: • Lab essentials and workflows to keep research moving day to day • Water purification systems for consistent lab performance • Raw and starting materials to support reliable manufacturing • Bioprocessing solutions and customized systems for your unique process needs • Ultrafiltration and downstream technologies to support scalable production • Contract testing and CDMO services to help you advance programs and meet quality requirements Whether you’re advancing a lead candidate, scaling a platform, or strengthening manufacturing readiness, we’ll connect you with experts who can help. | MilliporeSigma, the U.S. life science business of Merck KGaA, Darmstadt, Germany, partners with food safety teams to enable you to improve lab testing efficiencies with reliable products and services that meet ever changing regulations. It is through our collaborations that we can advance the safety and analysis of foods and beverages using trusted brands like Millipore® with microbiology solutions for hygiene, environmental monitoring & pathogen detection, Supelco® analytical solutions for analysis of food contamination and authenticity, Milli-Q® lab water solutions and Sigma Aldrich lab & production materials, including chemicals, inorganics & solvents throughout the supply chain, manufacturing and distribution. | MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany. MilliporeSigma’s portfolio spans more than 300,000 products enabling scientific discovery. MilliporeSigma has customers in life science companies, university and government institutions, hospitals and industry. More than 1 million scientists and technologists use its products. The company is committed to solving the toughest problems in life science by collaborating with the global scientific community. | MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany. With 19,000 employees and 72 manufacturing sites worldwide, MilliporeSigma’s portfolio spans more than 300,000 products enabling scientific discovery. MilliporeSigma has customers in life science companies, university and government institutions, hospitals and industry. More than 1 million scientists and technologists use its products. The company is committed to solving the toughest problems in life science by collaborating with the global scientific community. For more information, www.emdmillipore.com and www.sigma-aldrich.com.